Indrapr.Medical

42
Sell
  • Market Cap: Small Cap
  • Industry: Hospital
  • ISIN: INE681B01017
  • NSEID: INDRAMEDCO
  • BSEID: 532150
INR
362.55
1.9 (0.53%)
BSENSE

Nov 20

BSE+NSE Vol: 2.32 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2026 is 9.30% vs 8.97% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2026 is 9.27% vs 26.33% in Mar 2025

stock-summary

Interest

YoY Growth in year ended Mar 2026 is -3.99% vs 54.43% in Mar 2025

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2026 is 14.06% vs 29.87% in Mar 2025

Compare Profit and Loss Results of Indrapr.Medical
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
1,482.00
801.00
681.00
85.02%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
1,482.00
801.00
681.00
85.02%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
-8.00
8.00
100.00%
Raw Materials Consumed
0.00
100.00
-100.00
-100.00%
Power & Fuel Cost
24.00
0.00
24.00
0%
Employee Cost
287.00
148.00
139.00
93.92%
Operating Expenses
335.00
0.00
335.00
0%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
105.00
66.00
39.00
59.09%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
7.00
26.00
-19.00
-73.08%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
1,215.00
450.00
765.00
170.00%
Operating Profit (PBDIT) excl Other Income
266.00
350.00
-84.00
-24.00%
Other Income
28.00
8.00
20.00
250.00%
Operating Profit (PBDIT)
295.00
359.00
-64.00
-17.83%
Interest
6.00
13.00
-7.00
-53.85%
Profit before Depriciation and Tax
289.00
345.00
-56.00
-16.23%
Depreciation
43.00
47.00
-4.00
-8.51%
Profit Before Taxation & Exceptional Items
246.00
297.00
-51.00
-17.17%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
246.00
297.00
-51.00
-17.17%
Provision for Tax
62.00
75.00
-13.00
-17.33%
Profit After Tax
183.00
222.00
-39.00
-17.57%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
475.00
177.00
298.00
168.36%
Profit Available for appropriations
658.00
399.00
259.00
64.91%
Appropriations
658.00
399.00
259.00
64.91%
Equity Dividend (%)
40%
225%
-185.00
Earnings Per Share
20.03
17.87
2.16
12.09%
Profit And Loss - Net Sales
Net Sales 1,482.51 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 9.30% vs 8.97% in Mar 2025

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 266.92 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 9.27% vs 26.33% in Mar 2025

Profit And Loss - Interest
Interest 6.02 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is -3.99% vs 54.43% in Mar 2025

Profit And Loss - Profit After Tax
Profit After Tax 183.62 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 14.06% vs 29.87% in Mar 2025